A Scoping Review on Strategies that Enhance Medication Adherence in Children and Adolescents with Attention Deficit Hyperactivity Disorder and Associated Outcomes-Reference-Cited by-同舟云学术

A Scoping Review on Strategies that Enhance Medication Adherence in Children and Adolescents with Attention Deficit Hyperactivity Disorder and Associated Outcomes

Published:2024-06-05 Issue:3 Volume:11 Page:113-124
ISSN:2196-2987
Container-title:Current Developmental Disorders Reports
language:en
Short-container-title:Curr Dev Disord Rep

Author:

Valaei Sharif Nafiseh^ORCID,Ghasemzadeh Peivand^ORCID,Ghasemzadeh Sogand^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40474-024-00299-7.pdf

Reference42 articles.

1. Ayano G, Demelash S, Gizachew Y, Tsegay L, Alati R. The Global Prevalence of Attention Deficit Hyperactivity Disorder in Children and Adolescents: An umbrella review of meta-analyses. J Affect Disord. 2023;339:860–6.

2. Banaschewski T, Becker K, Döpfner M, Holtmann M, Rösler M, Romanos M. Attention-deficit/hyperactivity disorder-a current overview. Dtsch Arztebl Int. 2017;114(9):149–58.

3. Khan MU, Balbontin C, Bliemer MCJ, Aslani P. Eliciting Preferences for Continuing Medication among Adult Patients and Parents of Children with Attention-deficit Hyperactivity Disorder. Heal Expect. 2022;25(3):1094–107. This study emphasizes that side effects play a paramount role in determining the willingness to continue medication for both adults with ADHD and parents of children with ADHD, with parents prioritizing avoidance of severe side effects over educational improvements.

4. da Silva BS, Grevet EH, Silva LCF, Ramos JKN, Rovaris DL, Bau CHD. An Overview on Neurobiology and Therapeutics of Attention-deficit/hyperactivity Disorder. Discov Ment Heal. 2023;3(1).

5. Faraone S V., Asherson P, Banaschewski T, Biederman J, Buitelaar JK, Ramos-Quiroga JA, et al. Attention-deficit/hyperactivity Disorder. Nat Rev Dis Prim. 2015;1.